Lupin Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Analyst
Motilal Oswal Financial Services
Equibles does not estimate personal net worth.
Tushar Manudani is recorded as Analyst at Motilal Oswal Financial Services. Tushar Manudani has spoken on 3 earnings calls across 3 companies, most recently for Lupin Limited on November 4, 2026. Those appearances were for Lupin Limited, Alkem Laboratories Limited and Mankind Pharma Limited. The companies whose calls Tushar Manudani spoke on are classified in the Healthcare sector.
“Ma'am, if you could share your thoughts and further development work in the peptide segment, apart from whatever we have launched for the regulated markets, specifically U.S.”
“Good evening, everyone, and warm welcome for first quarter FY27 earnings call of Alcan Laboratories. From management side, we have Mr. Sandeep Singh, Managing Director, Mr. Nitin Agarwal, CFO, and Ms. Purvi Shah, Head of Investor Relations.”
“Secondly, on the consumer health side, while FY25 was pretty strong, but FY26, again, the growth has moderated. Fourth quarter, particularly, there was a low base effect, so 20% growth.”
Motilal Oswal Financial Services
Analyst
Transcript header (unverified)
Lupin Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Alkem Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Mankind Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Lupin Limited
“Alkem Laboratories Limited Q1 FY27 Earnings Conference Call”
Alkem Laboratories Limited
Earnings Call
Mankind Pharma Limited